Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Isshiki

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JCI Insight|September 21, 2022
Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysisYusuke Isshiki, Motohiko Oshima, Naoya Mimura, et al.
Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2023
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasmsAsuka Shibamiya, Yurie Miyamoto-Nagai, Shuhei Koide, et al.
Scientific Reports|January 23, 2021
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cellsYurie Nagai, Naoya Mimura, Ola Rizq, et al.
Cancer Cell|December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki, Xi Chen, Matt Teater, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Leukemia|January 13, 2019
Genetic and transcriptional landscape of plasma cells in POEMS syndromeYuhei Nagao, Naoya Mimura, June Takeda, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JCI Insight|September 21, 2022
Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysisYusuke Isshiki, Motohiko Oshima, Naoya Mimura, et al.
Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2023
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasmsAsuka Shibamiya, Yurie Miyamoto-Nagai, Shuhei Koide, et al.
Scientific Reports|January 23, 2021
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cellsYurie Nagai, Naoya Mimura, Ola Rizq, et al.
Cancer Cell|December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki, Xi Chen, Matt Teater, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Leukemia|January 13, 2019
Genetic and transcriptional landscape of plasma cells in POEMS syndromeYuhei Nagao, Naoya Mimura, June Takeda, et al.
Pageof 3